


Here I present: Victor McKusick, Mendelian Inheritance in Man’, 1966, Group #F.
INTRODUCTION.
“Genomic regions” is the topic of this blog post. Although anyone can get a DNA company, such as Ancestry, Familytree & 23&Me to give you “chromosomal paints”; the next steps to reading the nucleic“eighty-seven (87) & mitochondria one (1) reading regions” needs to be addressed.
I am going present genomic group #F (shown ABOVE) which is chromosome #19, and chromosomes #20 (shown BELOW).
Microsoft WORD has a “read-aloud” function. If you “copy & paste” the traits of genomic Group #F into a Microsoft WORD document; and press the “read-aloud” button you get a lesson. This lesson is reading-aloud of the Gateway chromosomes (free at Wikipedia); but now you just listen. Listening to the “read-aloud” over and over, allows you to learn the “nucleic eighty-seven (87) & mitochondria one (1) reading regions”.
Region 19p1 Traits.
Coxsackie virus sensitivity.
Ataxia, cerebellar, Cayman-type.
Cyclic hematopoiesis.
Convulsions, familial febrile.
Fucosyltransferase-6 deficiency.
Guanidinoacetate methyltransferase deficiency.
Hypocalciuric hypercalcemia, type II.
Muscular dystrophy.
Leukemia, myeloid/lymphoid or mixed lineage.
Hirschprung disease.
Wegener granulomatosis autoantigen.
Peutz-Jeghers syndrome.
Bleeding disorder.
Leukemia, acute lymphoblastic.
Persistent Müllerian duct syndrome, type I.
Atherosclerosis, susceptibility to.
Mucolipidosis.
Malaria, cerebral, susceptibility.
Glutaricaciduria, type I.
Sicca syndrome.
Leprechaunism.
Glioblastoma.
Rabson-Mendenhall syndrome.
Thyroid carcinoma, nonmedullary.
Diabetes mellitus, insulin’ resistant.
Low density lipoprotein receptor.
REGION 19q1 TRAITS.
Ichthyosis.
Hypercholesterolemia, familial.
Leukemia, T-cell acute lymphobloid.
Arteriopathy, cerebral.
Liposarcoma.
Pseudoachondroplasia.
Mycobacterial and salmonella infections, susceptibility to.
Epiphyseal dysplasia, multiple.
Eye color, green/blue.
Severe-combined, immunodeficiency disease.
Hemiplegic migraine, familial.
Hair color, brown.
Episodic ataxia, type 2.
Leigh syndrome.
Ataxia, spinocerebellar and cerebellar.
MHC class II deficiency.
Leukemia, acute myeloid.
Exostoses, multiple, type 3.
Mannosidosis, alpha, types I and II.
Benign familial infantile convulsions.
Alzheimer disease, late onset.
Leukemia/Lymphoma, B-cell.
Glomerulosclerosis, focal segmental.
Spondylocostal dysostosis, autosomal recessive.
Deafness, autosomal dominant.
Prostate-specific antigen.
Hypercalcemia, familial benign, Oklahoma type, type III.
Spastic paraplegia, autosomal dominant.
Orofacial cleft.
Cystinuria, types II and III.
Charcot-Leyden crystal protein.
Nephrosis, congenital, Finnish type.
Hemolytic anemia.
Generalized epilepsy with febrile seizures plus.
Hydrops fetalis.
Ovarian carcinoma.
Malignant hyperthermia susceptibility.
Microcephaly, autosomal recessive.
Central core disease.
Hyperlipoproteinemia, types 1b and III.
Osteodysplasia, polycystic lipomembranous.
Myocardial infarction susceptibility.
Maple syrup urine disease, type 1a.
Cytochrome P450 (coumarin resistance).
Camurati-Engelmann disease.
Nicotine addiction, protection from.
Myotonic dystrophy.
X-ray repair.
Heart block, progressive familial, type.
Excision repair.
Optic atrophy.
Xeroderma pigmentosum, group D.
3-methylglutaconiacaciduria, type III.
Trichothiodystropy.
Cystic fibrosis modifier.
DNA ligase I deficiency.
Meconium ileus in cystic fibrosis, susceptibility to.
Polio virus receptor.
Cone dystrophy.
Herpes virus entry mediator B.
Leber congenital amaurosis.
Glutaricaciduria, type IIB.
Retinitis pigmentosa, late-onset dominant.
Colorectal cancer.
Diabetes mellitus, noninsulin-dependent.
Leukemia, T-cell acute lymphoblastic.
Hyperferritinemia cataract syndrome.
Shaw-related subfamily genes.
Hypogonadism, hypergonadotropic.
Melanoma inhibitory activity.
Retinitis pigmentosa, autosomal dominant.
Cardiomyopathy, familial hypertrophic..
Ectodactyl, ectodermal dysplasia, cleft lip/palate.
REGION 20p1 TRAITS.
Creutzfeldt-Jakob disease. CJD
Diabetes insipidus, neurohypophyseal. CDI
Gerstmann-Straussler disease. GSD
McKusick-Kaufman syndrome. MKKS
Insomnia, fatal familial. FFI
Cerebral amyloid angiopathy. HCHWA
Pantothenate kinase associated neurodegeneration. NBIA1
Thrombophilia. THPH12
Alagille syndrome. ALGS1
Myocardial infarction, susceptibility. MCI1
Corneal dystrophy. FECD4
Huntington-like neurodegenerative disorder. HDL1
Inhibitor of DNA binding, dominant negative. ID1
Anemia, congenital dyserythropoietic. CDAN2
Facial anomalies syndrome. ICF1
Acromesomelic dysplasia, Hunter-Thompson type. AMD2C
Gigantism. GHRH
Brachydactyly, type C. BDC
Retinoblastoma. RBBP9
Chondrodysplasia, Grebe type. AMD2A
REGION 20q1 TRAITS.
Rous sarcoma. SRC
Hemolytic anemia. GSSDE
Colon cancer. CRC
Myeloid tumor suppressor. MLRL
Galactosialidosis. GSL
Breast cancer. CWS7
Severe combined immunodeficiency. SCID
Maturity Onset Diabetes of the Young, type 1. MODY1
Hemolytic anemia. GSSDE
Diabetes mellitus, noninsulin-dependent. T2D3
Obesity / hyperinsulinism. OBHP
Graves disease, susceptibility to. GRD2
Pseudohypoparathyroidism, type 1a. PHP1A
Epilepsy, nocturnal frontal lobe and benign neonatal, type 1. ENFL1
McCune-Albright polyostotic fibrous dysplasia. MAS
Epiphyseal dysplasia, multiple. EDM3
Somatotrophinoma. PITA3
Electo-encephalographic variant pattern. EEGL
Pituitary ACTH secreting adenoma. PITA3
Pseudohypoparathytroidism, type 1B. PHP1B
Shah-Waardenburg syndrome. WS4B

